2 Tang FP, Liu T. Hemoperfusion joint compound α keto acids in maintenance hemodialysis patients and to improve the nutritional status of micro-inflammation effect. Chinese Med Sci, 2013, 3(15): 168-70.
3 Bouhabel A, Saadi N, Bendjeddou J, et al. Diabetic nephropathy in hemodialysis patients in Constantine, Algeria. Saudi J Kidney Dis Transpl, 2015, 26(1): 139-40.
4 Xie JL, Nie QQ, Li XF. Effect of hematodialysis combined with hemoperfusion on the nutritional and micro-inflammatory state in the patients with diabetic nephropathy. J Hainan Med Coll, 2015, doi: 10.13210/j.cnki.jhmu.20150515.005.
6 Couchoud C, Savoye E, Frimat L, et al. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int, 2008, 28: 509-17.
8 Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation indevelopment of diabetes and its complications. J Clin Endocrinol Metab, 2009, 94(9): 3171-82.
10 Ghannoum M
, Bouchard J
, Nolin TD
, et al. Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. Semin Dial,
2014, 27(4): 350-61.
13 Zhang Y, Mei CL, Rong S, et al. Effect of the combination of hemodialysis and hemoperfusion on clearing advanced glycation end products: A prospective, randomized, two-stage crossover trial in patients under maintenance hemodialysis. Blood Purif, 2015, 40(2): 127-32.